Navigation Links
Lexicon Presents Clinical Data on LX1032 for Carcinoid Syndrome at European Neuroendocrine Tumor Society Meeting
Date:3/5/2009

THE WOODLANDS, Texas, March 5 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, announced today that Dr. Philip Brown, senior vice president of clinical development at Lexicon, delivered an oral presentation at the annual meeting of the European Neuroendocrine Tumor Society (ENETS). The presentation summarized Phase 1 clinical trial results for LX1032, Lexicon's orally-delivered small molecule drug candidate for managing gastrointestinal symptoms associated with carcinoid syndrome. The clinical studies, conducted to date in healthy volunteers, indicated that the drug candidate reduced serotonin levels in humans as predicted by Lexicon's mouse models and preclinical research. Lexicon is planning to initiate a Phase 2 clinical trial of LX1032 in patients with carcinoid syndrome in the first quarter of 2009.

A copy of the presentation will be available on the company's corporate website at www.lexpharma.com.

About ENETS

The ENETS conference is a medical conference focused on diagnosis and treatment of neuroendocrine tumors including carcinoid. The meeting brings together leading neuroendocrine tumor experts from around the world in such fields as oncology, pathology, radiology, nuclear medicine, endocrinology, surgery and gastroenterology. The 2009 ENETS conference runs from March 5-7 in Granada, Spain.

About Carcinoid Syndrome and LX1032

Ca
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Lexicon Initiates Phase 2a Trial of LX6171 Drug Candidate for Cognitive Disorders
2. Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis
3. Lexicon Reports Initial Clinical Trial Results for LX1031, an Investigational New Drug for Irritable Bowel Syndrome
4. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
5. Novagali Pharma Presents Results of its Innovative Latanoprost Formulation for Glaucoma
6. Spectral presents data on the clinical utility of EAA(TM) at 13th Annual Critical Care for Endotoxemia conference in Japan
7. Novavax Presents Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program at World Health Organization Conference
8. Genaera Presents Preliminary Phase 1b Data for Trodusquemine (MSI-1436)
9. Vermillion Presents Critical Data From Its OVA1 Clinical Trial
10. Sequoia Pharmaceuticals Presents Proof of Clinical Concept of SPI-452, a Novel Pharmacokinetic Enhancer
11. EntreMed Presents Initial Clinical Results for ENMD-2076
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... and KISSING, Germany , July 30, ... a single use and computer-assisted ("robotic") colonoscopy system, today ... a worldwide recognized medical device executive, as a new ... Shamir is a highly respected global visionary in the ... served as President and Chief Executive Officer at Given ...
(Date:7/30/2014)... PARIS , July 30, 2014  Regeneron ... (EURONEXT: SAN and NYSE: SNY ) today ... alirocumab in people with hypercholesterolemia met their primary efficacy ... low-density lipoprotein cholesterol (LDL-C) at 24 weeks compared to ... antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9). ...
(Date:7/30/2014)... VEGAS , July 30, 2014  DigiPath, Inc. ... that is expanding into the cannabis testing and education ... in its business and affairs not previously disclosed or, ... the recent unusual market action. "We have ... over the last three trading days," said Steve ...
Breaking Medicine Technology:invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 2invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8DigiPath No New Corporate Developments 2
... , , SAN DIEGO , Jan. 15 ... entry of a settlement agreement which will resolve the consolidated securities ... Master File No: 3:09-cv-00921-LAB-WMC. The defendants have agreed to pay ... the company has agreed to issue to the plaintiffs, class a ...
... , , , , , , ... Jan. 15 /PRNewswire-Asia-FirstCall/ -- China Sky One,Medical, Inc. ("China ... a,leading fully integrated pharmaceutical company developing and producing,over-the-counter drugs in ... the Company has relocated its headquarters to its new buildings,in ...
Cached Medicine Technology:Sequenom Announces Settlement Agreement In Shareholder Class Action Lawsuit 2Sequenom Announces Settlement Agreement In Shareholder Class Action Lawsuit 3Sequenom Announces Settlement Agreement In Shareholder Class Action Lawsuit 4China Sky One Medical, Inc. Completes and Moves into New Corporate Headquarters 2China Sky One Medical, Inc. Completes and Moves into New Corporate Headquarters 3
(Date:7/30/2014)... According to the market research report ... Technology (ICS, MES, ERP, ITS), Field Devices, Products ... (Process, Discrete) - Global Forecast & Analysis to ... market is expected to reach $6.99 Billion at ... 70 market data Tables and 96 Figures spread ...
(Date:7/30/2014)... 2014 “Today, we have said ¡Basta! ... are being promoted to our children and our families. ... the beverage industry to put the health of people ... Jane L. Delgado, President and CEO of the National ... Sugar-Sweetened Beverage Tax (SWEET) Act by Congresswoman Rosa L. ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 “North America ... market data on the North America Contrast Media Injectors ... dollars, and volume (in units) and average price data ...     CT Injectors ,     Interventional Cardiology/Angio Injectors and MRI ... contrast agent) is a substance used to enhance the ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 The Dr. ... Spohn Health, recently announced the proposed naming of the ... Dr. Hector P. Garcia Family Health Center. , The ... health care services, including comprehensive chronic disease management programs, ... also be a pioneering medical home model center. , ...
(Date:7/30/2014)... Decene is an alkene with ... ten carbon atoms with one double bond. 1-Decene ... It can be used as a co-monomer in ... epoxides, amines, oxo alcohols, synthetic lubricants, synthetic fatty ... will receive 10% customization on this report. , ...
Breaking Medicine News(10 mins):Health News:Mexico Factory Automation and Machine Vision Market Worth $6.99 Billion by 2020 - New Report by MarketsandMarkets 2Health News:Mexico Factory Automation and Machine Vision Market Worth $6.99 Billion by 2020 - New Report by MarketsandMarkets 3Health News:Mexico Factory Automation and Machine Vision Market Worth $6.99 Billion by 2020 - New Report by MarketsandMarkets 4Health News:National Alliance for Hispanic Health Statement on Introduction of SWEET Act 2Health News:Contrast Media Injectors Market in North America (US, Canada, Mexico) to 2020 Report Available at MarketOptimizer.org 2Health News:Contrast Media Injectors Market in North America (US, Canada, Mexico) to 2020 Report Available at MarketOptimizer.org 3Health News:Contrast Media Injectors Market in North America (US, Canada, Mexico) to 2020 Report Available at MarketOptimizer.org 4Health News:Dr. Hector P Garcia Memorial Foundation Supports New Health Care Facility 2Health News:Europe 1-decene Market is Expected to Reach 251.7 thousand MT in 2018 - New Report by MicroMarket Monitor 2Health News:Europe 1-decene Market is Expected to Reach 251.7 thousand MT in 2018 - New Report by MicroMarket Monitor 3Health News:Europe 1-decene Market is Expected to Reach 251.7 thousand MT in 2018 - New Report by MicroMarket Monitor 4
... TXStudents, perceptions of their overall experience on campus may ... research has also found a solid relationship between undergraduates, ... quality of life. Are campus green spaces as important ... new study investigating this question revealed some interesting insights. ...
... rule out men who don,t need treatment , MONDAY, ... the standard prostate cancer test can help improve predictions ... report. , The basic test measures blood levels of ... cells. But the standard PSA test cannot distinguish between ...
... 1st Plumbing ... Austin, Texas. The Easy Water system is a revolutionary alternative to salt-based water softeners. The ... your water, without them resulting in hard water buildup. , ... Austin, Texas -- 1st Plumbing Services has been selected as ...
... observational studies show an increased risk for cancer among ... may be worse than currently known. "As ... to see the current disparity in knowledge and outcomes ... of the Institute for Health Promotion Research at the ...
... lung cancer clinical trial to guide targeted therapies to ... a step toward personalized care and more effective, efficient ... during the American Association for Cancer Research 101st Annual ... M. D. Anderson Cancer Center presented the results of ...
... black children in kindergarten, first grade , MONDAY, April ... urban elementary school children, U.S. researchers report. , They ... 44 schools across the bi-state Kansas City metropolitan area, ... with the fungus ( T. tonsurans ) that causes ...
Cached Medicine News:Health News:Campus green space more important for undergrads 2Health News:New Test May Predict Prostate Cancer's Aggressiveness 2Health News:New Test May Predict Prostate Cancer's Aggressiveness 3Health News:1st Plumbing Services Selected to be Exclusive Dealer in Austin, Texas for Installation of Easy Water No-Salt Water Conditioning System 2Health News:1st Plumbing Services Selected to be Exclusive Dealer in Austin, Texas for Installation of Easy Water No-Salt Water Conditioning System 3Health News:Cancer health disparities research highlighted at AACR 101st Annual Meeting 2010 2Health News:Cancer health disparities research highlighted at AACR 101st Annual Meeting 2010 3Health News:Cancer health disparities research highlighted at AACR 101st Annual Meeting 2010 4Health News:Cancer health disparities research highlighted at AACR 101st Annual Meeting 2010 5Health News:Cancer health disparities research highlighted at AACR 101st Annual Meeting 2010 6Health News:Cancer health disparities research highlighted at AACR 101st Annual Meeting 2010 7Health News:BATTLE links potential biomarkers to drugs for lung cancer 2Health News:BATTLE links potential biomarkers to drugs for lung cancer 3Health News:BATTLE links potential biomarkers to drugs for lung cancer 4Health News:Resistant Ringworm Common in Urban Elementary Schools 2
... AFO is designed to treat or help ... immobility such as hip displasia, foot drop, ... A comfortable Kodel lining provides a comfortable ... anti-rotation bar is easily rotated and locked ...
... RCAI provides adjustable static stretch of the ... as diminished foot and ankle range of ... straps attached to the sides of the ... be controlled, as needed, in the desired ...
... Splint is indicated for the treatment of ... economical and easy to apply. The splint ... dorsiflexion, limiting nightly contractures and tightening of ... feature permits flexibility in the treatment of ...
This popular post op shoe provides quality care at an outstanding value. The semi-rigid outsole provides stability and minimizes flexure....
Medicine Products: